Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-18-028044
Filing Date
2018-09-11
Accepted
2018-09-11 08:48:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 35760
2 filename2.txt TEXT-EXTRACT 5643
  Complete submission text file 0000000000-18-028044.txt   55488
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filed for) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)